Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,089 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durable biochemical response and safety with oral octreotide capsules in acromegaly.
Samson SL, Nachtigall LB, Fleseriu M, Jensterle M, Manning PJ, Elenkova A, Molitch ME, Ludlam WH, Patou G, Haviv A, Biermasz NR, Giustina A, Strasburger CJ, Kennedy L, Melmed S. Samson SL, et al. Among authors: kennedy l. Eur J Endocrinol. 2022 Oct 26;187(6):733-741. doi: 10.1530/EJE-22-0220. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36173649 Free PMC article. Clinical Trial.
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.
Labadzhyan A, Nachtigall LB, Fleseriu M, Gordon MB, Molitch M, Kennedy L, Samson SL, Greenman Y, Biermasz N, Bolanowski M, Haviv A, Ludlam W, Patou G, Strasburger CJ. Labadzhyan A, et al. Among authors: kennedy l. Pituitary. 2021 Dec;24(6):943-953. doi: 10.1007/s11102-021-01163-2. Epub 2021 Jun 25. Pituitary. 2021. PMID: 34173129 Free PMC article. Clinical Trial.
Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide.
Samson SL, Nachtigall LB, Fleseriu M, Gordon MB, Bolanowski M, Labadzhyan A, Ur E, Molitch M, Ludlam WH, Patou G, Haviv A, Biermasz N, Giustina A, Trainer PJ, Strasburger CJ, Kennedy L, Melmed S. Samson SL, et al. Among authors: kennedy l. J Clin Endocrinol Metab. 2020 Oct 1;105(10):e3785-97. doi: 10.1210/clinem/dgaa526. J Clin Endocrinol Metab. 2020. PMID: 32882036 Free PMC article. Clinical Trial.
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.
Labadzhyan A, Nachtigall LB, Fleseriu M, Gordon MB, Molitch M, Kennedy L, Samson SL, Greenman Y, Biermasz N, Bolanowski M, Haviv A, Ludlam W, Patou G, Strasburger CJ. Labadzhyan A, et al. Among authors: kennedy l. Pituitary. 2021 Dec;24(6):954. doi: 10.1007/s11102-021-01177-w. Pituitary. 2021. PMID: 34347226 Free PMC article. No abstract available.
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes.
Fleseriu M, Auchus RJ, Greenman Y, Zacharieva S, Geer EB, Salvatori R, Pivonello R, Feldt-Rasmussen U, Kennedy L, Buchfelder M, Biller BM, Cohen F, Heaney AP. Fleseriu M, et al. Among authors: kennedy l. Eur J Endocrinol. 2022 Nov 24;187(6):859-871. doi: 10.1530/EJE-22-0506. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36251618 Free PMC article. Clinical Trial.
Lipodystrophy in patients with acromegaly receiving pegvisomant.
Bonert VS, Kennedy L, Petersenn S, Barkan A, Carmichael J, Melmed S. Bonert VS, et al. Among authors: kennedy l. J Clin Endocrinol Metab. 2008 Sep;93(9):3515-8. doi: 10.1210/jc.2008-0833. Epub 2008 Jul 8. J Clin Endocrinol Metab. 2008. PMID: 18611977
Acromegaly: a clinical perspective.
Lawrence L, Alkwatli K, Bena J, Prayson R, Kshettry V, Recinos P, Hatipoglu B, Pantalone KM, Weil R, Hamrahian AH, Kennedy L, Yogi-Morren D. Lawrence L, et al. Among authors: kennedy l. Clin Diabetes Endocrinol. 2020 Aug 20;6:15. doi: 10.1186/s40842-020-00104-5. eCollection 2020. Clin Diabetes Endocrinol. 2020. PMID: 32843993 Free PMC article.
1,089 results